MarketInOut Stock Screener Log In | Sign Up

Achieve Life Sciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Achieve Life Sciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization704.19 mln
Float69.81 mln
Earnings Date11/05/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

14.15
Transformational upside

Relative Strength

88 / 100
Strongly outperforming

ROE

-614
Deeply negative

ROA

-151
Deeply negative

Business Description

Achieve Life Sciences is a pharmaceutical company based in Bothell, Washington, focused on helping people quit smoking. Its lead product, cytisinicline, is a naturally derived compound that works by targeting nicotine receptors in the brain, easing the discomfort of withdrawal. The company operates across the United States, Canada, and the United Kingdom, supported by agreements with Sopharma AD and the University of Bristol for licensing and supply.

Key Fundamentals

EPS-1.69
ROE-614
ROIC-127
ROA-151
Interest Cover-58.63
EBITDA, mln-113
EV / EBITDA-4.26
EV / EBIT-4.25

Quote Details

Last 6.83
Change -0.36 (-5.01%)
Open 7.12
Volume 1,376,391
Turnover 9,400,750
Average Volume 1,334,962

Financial Ratios

Current Ratio0.95
PEG Ratio17.68

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price14.15
Short Ratio12.17
Short % of Float17.37

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.24% 89 / 100   
1 Month -9.3% 30 / 100   
2 Months 10.52% 88 / 100   
6 Months 55.94% 96 / 100   
1 Year 37.98% 88 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog